Fertility warning
This medicine may affect fertility.
Leaflet GEMCITABINA KABI 38mg / ml concentrate for solution for infusion
- Product code:
- W65009003
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- infusion
- Substance:
- gemcitabine (antimetabolite antineoplastic)
- ATC
- L01BC05 — Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Gemcitabine is a chemotherapy medication used to treat various types of cancer, including lung, pancreatic, breast, and bladder cancer. It is an antimetabolite that interferes with DNA synthesis in cancer cells.
This medication is administered intravenously, usually in cycles, according to a schedule set by the doctor. Gemcitabine helps slow the growth and spread of cancer cells.
Common side effects include nausea, vomiting, fatigue, low blood cell counts, and hair loss. In rare cases, severe reactions such as liver or lung function impairment may occur.
It is essential to follow your doctor's instructions and undergo regular tests to monitor the treatment's effects and manage potential side effects.
This medication is administered intravenously, usually in cycles, according to a schedule set by the doctor. Gemcitabine helps slow the growth and spread of cancer cells.
Common side effects include nausea, vomiting, fatigue, low blood cell counts, and hair loss. In rare cases, severe reactions such as liver or lung function impairment may occur.
It is essential to follow your doctor's instructions and undergo regular tests to monitor the treatment's effects and manage potential side effects.
General data about GEMCITABINA KABI 38mg / ml
- Substance:
- gemcitabine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65009003
- Concentration:
- 38mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 383.53 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for gemcitabine
Concentrations available for gemcitabine
- 1000mg
- 100mg/ml
- 10mg/ml
- 1g
- 2000mg
- 200mg
- 38mg/ml
- 40mg/ml